Middle East and Africa Dialysis Equipment Market
No. of Pages: 150 | Report Code: BMIPUB00031649 | Category: Life Sciences
No. of Pages: 150 | Report Code: BMIPUB00031649 | Category: Life Sciences
The Middle East and Africa dialysis equipment market size is expected to reach US$ 382.7 million by 2031 from US$ 346.9 million in 2024. The market is estimated to record a CAGR of 1.4% from 2025 to 2031.
The dialysis equipment market in Middle East and Africa is experiencing significant growth driven by increasing growth of kidney disease. Dramatically rising trends of CKD and ESRD, primarily as a comorbidity (diabetes and hypertension) are driving this growth.
The Middle East and Africa region has some of the highest rates of diabetes in the world with 73 million adults currently affected and expected to reach 136 million by 2045. Countries like Saudi Arabia and Egypt having rates of diabetes prevalence over 20% in some defined populations. Hypertension is being recognized as an important driver of CKD as it is estimated over 30% of adults in the region have high blood pressure thus raising concern of CKD and ESRD.
Furthermore, progress due to early awareness and preventative screening is a very important catalyst driving the growth of this market. Engagement through public health campaigns to educate people about the importance of early detection and management of kidney diseases is central to their prevention from advancing to ESRD. Cultural factors have important influence on healthcare seeking behaviour. Initiatives are underway to address this in order to better serve populations. The preference for home-based dialysis solutions is increasing, particularly in response to concerns about hospital-acquired infections and the need for more flexible treatment options.
Despite challenges such as regional disparities in healthcare access and the need for infrastructure improvement, the MEA region holds substantial growth potential, especially as healthcare systems modernize and international investments in healthcare continue to rise.
Middle East and Africa Dialysis Equipment Market Segmentation Analysis:
Key segments that contributed to the derivation of the dialysis equipment market analysis are product, application, and end user.
The Middle East and Africa dialysis equipment market is segmented into Turkiye, UAE, Saudi Arabia, Bahrain, Oman, Egypt, South Africa, Algeria, Nigeria, Kuwait, and Qatar. The Middle East & Africa (MEA) dialysis equipment market is undergoing significant expansion in 2024, propelled by a critical and escalating burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD). For instance, the mean prevalence of ESRD in GCC countries (part of the Middle East) was 551 per million population (pmp).
Healthcare spending in the Gulf Cooperation Council has been estimated between 2 percent and 5.5 percent of GDP thus, with significant increases expected, including an estimated 12 percent increase in medical healthcare spending in the Middle East in 2025. The unique challenges faced by the Middle East, including limited skilled workforce, and different reimbursement polices outcome unprecedented economic growth of dialysis and health care infrastructure, particularly in some African nations, yet the sheer patient volume and increasing government and private investments are ensuring a steady market expansion.
Based on region, the Middle East and Africa dialysis equipment market is further segmented into the Turkiye, UAE, Saudi Arabia, Bahrain, Oman, Egypt, South Africa, Algeria, Nigeria, Kuwait, and Qatar. The Turkiye held the largest share in 2024.
The dialysis equipment industry in Turkiye is heavily affected by the demographics of the population, including demographics related to the unavoidable epidemic problem of chronic disease. There is a notable upward trend of persons aged 65 and older who accounted for 106% of the population, and this is projected to rise from 9.1% in 2019 according to the statistics from TURKSTAT released in March 2025. In terms of those who are most at risk for kidney disease, this is an important statistic. The public health issue of chronic kidney disease (CKD) is a recognized problem with an expected overall prevalence of 12.3% in regards to the general population of Turkiye by 2027 including a large proportion of cases that remain undiagnosed. There appears to be an established trend between the burgeoning chronic disease problem in Turkiye and the high rates of chronic disease (particularly diabetes and hypertension) that lead to kidney damage. Based on an analysis of pre-existing conditions described in the WHO (2023) country profile on Turkiye, diabetes prevalence was projected to be 158% for the Turkish population in 2023, and this is expected to rise to 191% by 2045. Hypertension also remains high, and as it relates particularly to cardiovascular health and prevalence rates end-stage renal disease (ESRD)-- this reality represents a large and growing group of patients requiring kidney replacement therapy. As noted by the Turkish Society of Nephrology (2023) Registry released in April 2025, there were 89,527 patients receiving kidney replacement therapy by the end of 2023. This translates to a prevalence of 1,048.7 patients per million population. Hemodialysis remains the predominant treatment modality, utilized by 70.88% of prevalent patients in 2023, while diabetes was identified as the most frequent cause of ESRD among new patients initiating therapy (33.9%) in the same year. The continuous growth in the number of dialysis patients underscores the persistent demand for dialysis equipment and related consumables across Turkiye.
The dialysis equipment market in South Africa is fundamentally shaped by a growing burden of CKD driven by prevalent non-communicable diseases, set against the backdrop of a gradually aging population and healthcare sector disparities. While the country maintains a relatively youthful demographic compared to some developed nations, the proportion of individuals aged 60 and above is steadily increasing, reaching ~9.7% (6.13 million) in 2024, according to Statistics South Africa. This demographic shift contributes to a larger population susceptible to kidney ailments. CKD is a significant health challenge, with estimates of its prevalence varying but consistently linked to high rates of diabetes and hypertension. Diabetes affected 11.3% of South African adults (IDF data), and recent studies continue to underscore its high incidence, noting its role in accelerating CKD progression.
Middle East and Africa Dialysis Equipment Market Company Profiles
Fresenius Medical Care AG & Co KGaA; Baxter International Inc.; B. Braun SE; Nipro Corp; Medtronic Plc, Nikkiso Co Ltd, Teleflex Inc, Asahi Kasei Medical Co., Ltd., Terumo Corp, and DaVita Inc. are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The Middle East and Africa Dialysis Equipment Market is valued at US$ 346.9 Million in 2024, it is projected to reach US$ 382.7 Million by 2031.
As per our report Middle East and Africa Dialysis Equipment Market, the market size is valued at US$ 346.9 Million in 2024, projecting it to reach US$ 382.7 Million by 2031. This translates to a CAGR of approximately 1.4% during the forecast period.
The Middle East and Africa Dialysis Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Dialysis Equipment Market report:
The Middle East and Africa Dialysis Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Dialysis Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Dialysis Equipment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Dialysis Equipment Market
